1887

n South African Pharmaceutical and Cosmetic Review - Datamonitor predicts demand for in-licensing deals : pharmaceutical focus

USD

 

Abstract

Continued demand for innovative and potentially first-in-class medicines is driving up the cost and driving down the potential return on investment for late stage inlicensing deals, pushing the pharmaceutical industry to be more creative as it tries to lessen the impact of patent expiries, finds independent market analyst Datamonitor.

Loading

Article metrics loading...

/content/im_sapcr/37/8/EJC41308
2010-08-01
2016-12-04
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error